Clinical Trial Update: Feasibility Study of Extended-release Naltrexone (Vivitrol) in Drug Court Settings [Phase 4]

View source ↗

Summary

A Phase 4 feasibility study evaluated extended-release naltrexone (Vivitrol) in drug court settings for opioid-related disorders; study completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-related Disorders

Drugs mentioned

• Vivitrol (naltrexone extended-release injectable)

Snippet

Sponsor: Duke University | Conditions: Opioid-Related Disorders | Phase 4 | Status: COMPLETED | Results posted: 2020-06-16